| Friedland, Barbara |
NCT05128136: A Crossover Study Evaluating 3 Non-medicated Silicone IVRs |
|
|
| Completed | N/A | 48 | US | Impact of ring size on adherence | Population Council, Albert Einstein College of Medicine, Emory University | Hiv, Pregnancy Related | 12/22 | 01/23 | | |
NCT04778514: A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention |
|
|
| Completed | N/A | 30 | RoW | Dual Prevention Pill, DPP, PrEP and combined oral contraceptive (COC) as two separate tablets, Truvada, Zinnia F | Population Council, University of Zimbabwe | HIV Infections, Contraception | 09/23 | 09/23 | | |
NCT04778527: A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention |
|
|
| Active, not recruiting | N/A | 96 | RoW | Dual Prevention Pill, DPP, PrEP tablet and a COC as two separate tablets, Truvada, Zinnia F | Population Council | HIV Infections | 01/24 | 01/24 | | |
| Palanee-Phillips, Thesla |
EPIC, NCT04669678: Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa |
|
|
| Completed | 4 | 108 | RoW | Etonogestrel (ETG) implant, Intramuscular depo-medroxyprogesterone acetate (IM DMPA), Sub-cutaneous medroxyprogesterone acetate (SC MPA), Non-hormonal intrauterine device (IUD) | University of Alabama at Birmingham, Merck Sharp & Dohme LLC, Wits Reproductive Health and HIV Institute, University of Washington | HIV Infections, Contraception, Drug-drug Interaction | 02/24 | 02/24 | | |
| Recruiting | 1 | 100 | US, RoW | Placebo Intravaginal Ring A, Placebo Intravaginal Ring B | University of Pittsburgh, United States Agency for International Development (USAID), Oak Crest Institute of Science | Safety, Acceptability | 12/24 | 12/25 | | |
NCT06046053: MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films |
|
|
| Recruiting | 1 | 100 | US, RoW | Placebo Vaginal Film with Square Corners, Placebo Vaginal Film with Rounded Corners | Rohan, Lisa, PhD, United States Agency for International Development (USAID) | Safety, Acceptability, Usability | 10/24 | 04/25 | | |
| Active, not recruiting | N/A | 184 | RoW | Placebo injection: Intralipid 20% fat emulsion, Placebo implant | RTI International | Acceptability | 08/24 | 10/24 | | |
NCT04778527: A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention |
|
|
| Active, not recruiting | N/A | 96 | RoW | Dual Prevention Pill, DPP, PrEP tablet and a COC as two separate tablets, Truvada, Zinnia F | Population Council | HIV Infections | 01/24 | 01/24 | | |
PALESA, NCT06030856: PrEP Restart for Adolescent Girls and Young Women Using STI Self Testing and Assessment of Risk |
|
|
| Recruiting | N/A | 50 | RoW | STI test kits (NG, CT and TV) for home use, Self Administered Behavioural Risk Assessment | Wits RHI Research Centre Clinical Research Site, University of Alabama at Birmingham, University of California, San Francisco | HIV Prevention | 08/24 | 08/24 | | |
| Zulu, Sihle |
| Active, not recruiting | N/A | 184 | RoW | Placebo injection: Intralipid 20% fat emulsion, Placebo implant | RTI International | Acceptability | 08/24 | 10/24 | | |
NCT04778527: A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention |
|
|
| Active, not recruiting | N/A | 96 | RoW | Dual Prevention Pill, DPP, PrEP tablet and a COC as two separate tablets, Truvada, Zinnia F | Population Council | HIV Infections | 01/24 | 01/24 | | |
| Ndlovu, Nkosiphile |
| Recruiting | 1 | 100 | US, RoW | Placebo Intravaginal Ring A, Placebo Intravaginal Ring B | University of Pittsburgh, United States Agency for International Development (USAID), Oak Crest Institute of Science | Safety, Acceptability | 12/24 | 12/25 | | |
NCT06046053: MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films |
|
|
| Recruiting | 1 | 100 | US, RoW | Placebo Vaginal Film with Square Corners, Placebo Vaginal Film with Rounded Corners | Rohan, Lisa, PhD, United States Agency for International Development (USAID) | Safety, Acceptability, Usability | 10/24 | 04/25 | | |
NCT04778527: A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention |
|
|
| Active, not recruiting | N/A | 96 | RoW | Dual Prevention Pill, DPP, PrEP tablet and a COC as two separate tablets, Truvada, Zinnia F | Population Council | HIV Infections | 01/24 | 01/24 | | |
